ID   NZM025
AC   CVCL_S430
SY   NZM25
DR   Wikidata; Q54931552
RX   CelloPub=CLPUB00227;
RX   PubMed=32567790;
CC   Doubling time: 37.1 hours (CelloPub=CLPUB00227).
ST   Source(s): PubMed=32567790
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D13S317: 13
ST   D16S539: 10,11
ST   D18S51: 17,19
ST   D19S433: 14
ST   D21S11: 30,31.2
ST   D2S1338: 25
ST   D3S1358: 15,18
ST   D5S818: 10,12
ST   D7S820: 10
ST   D8S1179: 10,14
ST   FGA: 20,23
ST   TH01: 8,9.3
ST   TPOX: 8,12
ST   vWA: 15,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 6
//
RX   CelloPub=CLPUB00227;
RA   Daukste L.;
RT   "Mathematical modelling of cancer cell population dynamics.";
RL   Thesis PhD (2012); University of Canterbury; Christchurch; New Zealand.
//
RX   PubMed=32567790; DOI=10.1111/pcmr.12908; PMCID=PMC7818249;
RA   Tran K.B., Gimenez G., Tsai P., Kolekar S., Rodger E.J.,
RA   Chatterjee A., Jabed A., Shih J.-H., Joseph W.R., Marshall E.S.,
RA   Wang Q., Print C.G., Eccles M.R., Baguley B.C., Shepherd P.R.;
RT   "Genomic and signalling pathway characterization of the NZM panel of
RT   melanoma cell lines: a valuable model for studying the impact of
RT   genetic diversity in melanoma.";
RL   Pigment Cell Melanoma Res. 34:136-143(2021).
//